Policy
More in Policy
When relations with China worsen, science suffers
Legislation introduced in Congress and a presidential proclamation aim to restrict student and research visas for Chinese graduate students.
Ex-Emory neuroscientist pleads guilty; fired Cleveland Clinic geneticist arrested
Department of Justice continues to pursue scientists who fail to disclose ties to China’s Thousand Talents Program.
3 volunteering guidelines to heed during the coronavirus pandemic
A volunteering expert offers guidance on how to help at a time when you might need to keep your helping hands to yourself.
Out of my comfort zone: How I use science to influence policy
When Amanda Koch realized that elected officials often do not make evidence-based decisions, she decided she wanted her scientific voice to be heard in politics.
Federal agencies struggle to address sexual harassment in STEM research
A Q&A with John Neumann of the General Accountability Office, whose team produced a report in March on federal funding agencies’ dealings with sexual harassment.
Air pollution could make people more vulnerable to COVID-19
Air pollution hits harder in communities of color. Such exposures could lead to increased risks from the new coronavirus.
What the Supreme Court's DACA ruling means for undocumented students and the colleges and universities they attend
More in Policy
How is COVID-19 affecting NIH research?
The ASBMB hosted a webinar with NIH officials to outline how they’re helping scientists navigate pandemic-related interruptions to their research.
Podcast series documents COVID-19 experiences
Special series of Pipettes & Politics includes interviews with faculty members, a first responder, NIGMS leader Jon Lorsch and others.
In the rush to innovate for COVID-19 drugs, sound science is still essential
To battle the coronavirus, strong regulatory protection from the FDA is essential.
Funding agencies relax rules amid pandemic
A roundup of how the NIH, NSF and DOE are accommodating grant applicants and recipients during the COVID-19 outbreak.
Protecting American science and its international collaborators
Lawyer and professor Frank Wu spoke about research integrity, legal cases against scientists and foreign influences on federally funded research.
Why hoarding of hydroxychloroquine needs to stop
Some old antimalarial drugs are becoming harder to get in the United States, partly because President Donald Trump has touted them as a potential treatment for COVID-19.
Join the ASBMB Today mailing list
Sign up to get updates on articles, interviews and events.